drugset / Trial / NCT06301997
A Herbal Compound for Psoriasis
Phase 2
Active not recruiting
104 enrolled
Fasa University of Medical Sciences
Herbmedx Co · collabZarrin Avaye Kowsar Salamat (ZAX company) and HerbmedX · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this interventional clinical trial study is to compare ZAX.1400.P03 and placebo in Psoriasis patients. The main question it aims to answer is: • Can treatment with ZAX.1400.P03 for 3 weeks improve clinical signs of skin in psoriasis patients? Participants will be divided into two groups of 52 people. One group will use ZAX.1400.P03 topically twice daily for 3 weeks and the other group will use placebo topically twice daily for 3 weeks. Researchers will compare treatment and placebo groups to see if there is any improvement in the clinical signs of skin caused by psoriasis after treatment with ZAX.1400.P03 for 3 weeks.
Timeline
- Start
- 2023-02-01
- Primary completion
- 2025-06-30
- Completion
- 2025-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZAX.1400.P03 | Unknown | — | Topical |